Evidence map›Paper›PMID 32384907›Full record

ArticleParasites & vectors2020

Anopheles gambiae (s.l.) exhibit high intensity pyrethroid resistance throughout Southern and Central Mali (2016-2018): PBO or next generation LLINs may provide greater control.

Arthur Sovi, Chitan Keita, Youssouf Sinaba, Abdourhamane Dicko, Ibrahim Traore, Moussa B M Cisse, Ousmane Koita, Dereje Dengela, Cecilia Flatley, Elie Bankineza and 5 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bio-efficacy of OlysetTropical medicine and health · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pyrethroid and Etofenprox Resistance inMolecules (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Arthur SoviFaculty of Agronomy, University of Parakou, BP123, Parakou, Benin. arthur.sovi@lshtm.ac.uk.
Chitan KeitaPMI VectorLink Project, Abt Associates, Cite du Niger 1, Rue 30, Porte 612, Bamako, Mali.
Youssouf SinabaPMI VectorLink Project, Abt Associates, Cite du Niger 1, Rue 30, Porte 612, Bamako, Mali.
Abdourhamane DickoProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé, Bamako, Mali.
Ibrahim TraoreUniversité des Sciences, des Techniques, et des Technologies de Bamako (USTTB), Bamako, Mali.
Moussa B M CisseUniversité des Sciences, des Techniques, et des Technologies de Bamako (USTTB), Bamako, Mali.
Ousmane KoitaUniversité des Sciences, des Techniques, et des Technologies de Bamako (USTTB), Bamako, Mali.
Dereje DengelaPMI VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Cecilia FlatleyPMI VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Elie BankinezaPMI VectorLink Project, Abt Associates, Cite du Niger 1, Rue 30, Porte 612, Bamako, Mali.
Jules MihigoU.S. President's Malaria Initiative, U.S. Agency for International Development, Bamako, Mali.
Allison BelemvireU.S. President's Malaria Initiative, U.S. Agency for International Development, Washington, DC, USA.
Jenny CarlsonU.S. President's Malaria Initiative, U.S. Agency for International Development, Washington, DC, USA.
Christen FornadelU.S. President's Malaria Initiative, U.S. Agency for International Development, Washington, DC, USA.
Richard M OxboroughPMI VectorLink Project, Abt Associates, 6130 Executive Blvd, Rockville, MD, 20852, USA.
Université des Sciences, des Techniques et des Technologies de Bamako · MLU.S. President's Malaria Initiative · USVector (United States) · USAbt Global (United States) · USCentre Pour le Développement des Vaccins-Mali · MLInnovative Vector Control Consortium · GBUniversité de Parakou · BJ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMillions of pyrethroid LLINs have been distributed in Mali during the past 20 years which, along with agricultural use, has increased the selection pressure on malaria vector populations. This study investigated pyrethroid resistance intensity and susceptible status of malaria vectors to alternative insecticides to guide choice of insecticides for LLINs and IRS for effective control of malaria vectors.

methodsFor 3 years between 2016 and 2018, susceptibility testing was conducted annually in 14-16 sites covering southern and central Mali. Anopheles gambiae (s.l.) were collected from larval sites and adult mosquitoes exposed in WHO tube tests to diagnostic doses of bendiocarb (0.1%) and pirimiphos-methyl (0.25%). Resistance intensity tests were conducted using CDC bottle bioassays (2016-2017) and WHO tube tests (2018) at 1×, 2×, 5×, and 10× the diagnostic concentration of permethrin, deltamethrin and alpha-cypermethrin. WHO tube tests were conducted with pre-exposure to the synergist PBO followed by permethrin or deltamethrin. Chlorfenapyr was tested in CDC bottle bioassays at 100 µg active ingredient per bottle and clothianidin at 2% in WHO tube tests. PCR was performed to identify species within the An. gambiae complex.

resultsIn all sites An. gambiae (s.l.) showed high intensity resistance to permethrin and deltamethrin in CDC bottle bioassay tests in 2016 and 2017. In 2018, the WHO intensity tests resulted in survivors at all sites for permethrin, deltamethrin and alpha-cypermethrin when tested at 10× the diagnostic dose. Across all sites mean mortality was 33.7% with permethrin (0.75%) compared with 71.8% when pre-exposed to PBO (4%), representing a 2.13-fold increase in mortality. A similar trend was recorded for deltamethrin. There was susceptibility to pirimiphos-methyl, chlorfenapyr and clothianidin in all surveyed sites, including current IRS sites in Mopti Region. An. coluzzii was the primary species in 4 of 6 regions.

conclusionsWidespread high intensity pyrethroid resistance was recorded during 2016-2018 and is likely to compromise the effectiveness of pyrethroid LLINs in Mali. PBO or chlorfenapyr LLINs should provide improved control of An. gambiae (s.l.). Clothianidin and pirimiphos-methyl insecticides are currently being used for IRS as part of a rotation strategy based on susceptibility being confirmed in this study.

Indexed as

AnophelesInsecticide ResistanceInsecticidesPiperonyl ButoxidePyrethrinsAnimalsBiological AssayFemaleInsecticide-Treated BednetsLarvaMalariaMaliMosquito ControlMosquito VectorsInsecticidesPiperonyl ButoxidePyrethrinsAnopheles gambiaeCDC bottle bioassayIndoor residual sprayingLong-lasting insecticidal netMaliPiperonyl butoxideResistance intensitySusceptibility testVector controlWHO tube test

Identifiers

PMID32384907
PMCPMC7206711
OpenAlexW3022437413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.